ClinicalTrials.Veeva

Menu

Impulse Oscillation to Evaluate Diagnostic Efficacy in Patients With Chronic Airway Disease

Z

Zhujiang Hospital

Status

Unknown

Conditions

Chronic Airway Disease

Treatments

Diagnostic Test: bronchial provocation test(BPT)
Diagnostic Test: bronchial dilation test(BDT)
Diagnostic Test: impulse oscillation(IOS)

Study type

Interventional

Funder types

Other

Identifiers

NCT04668027
2020LX0007_ZD

Details and patient eligibility

About

The aim of the research is to explore the diagnostic efficacy of impulse oscillation (IOS) before and after bronchial provocation test (BPT) and bronchial dilation test (BDT) in chronic airway disease.

Full description

The present study has the following objectives:

to explore the diagnostic value of IOS before and after BPT/BDT in chronic airway disease, to assess the diagnostic accuracy of IOS in chronic airway disease with special regard to its discriminating value between asthma and chronic obstructive pulmonary disease, to evaluate the characteristics of airway resistance after BPT/BDT, to evaluate the airway reversibility and hyperresponsiveness(AHR)in asthma.

Enrollment

172 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. 18-75 years old, no gender limit;

  2. The subject voluntarily cooperated with the research and signed an informed consent form;

  3. Meet any of the following three criteria:

    • Patients with asthma, the standard diagnosis of asthma complied with the GINA 2019; ② Patients with COPD, the standard diagnosis of COPD complied with GOLD 2019; ③ The subjects in the healthy control group had normal vital capacity (baseline FEV1≥80% of the predicted value, FEV1/FVC was greater than the Lower Limit of Normal, and with negative result of BPT or BDT).

Exclusion criteria

  1. History of other lung diseases, such as cystic fibrosis, bronchiolitis obliterans, tuberculosis, lung cancer, etc.;
  2. After taking corticosteroid therapy in the last 4 weeks, respiratory tract infection occurred within 8 weeks;
  3. A history of myocardial infarction and stroke in the past 3 months; a history of severe arrhythmia, severe cardiac insufficiency, and unstable angina in the past 4 weeks, etc.;
  4. In the past 4 weeks, severe hemoptysis and epileptic seizures require medication; severe hyperthyroidism;
  5. Pregnant women;
  6. Other researchers consider it inappropriate.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

172 participants in 1 patient group

chronic airway disease group
Experimental group
Description:
Before the test, patients with FEV1/FVC≥0.7 are divided into the provocation test group, patients with FEV1/FVC \<0.7 are divided into the dilation test group.
Treatment:
Diagnostic Test: bronchial provocation test(BPT)
Diagnostic Test: bronchial dilation test(BDT)
Diagnostic Test: impulse oscillation(IOS)

Trial contacts and locations

1

Loading...

Central trial contact

Huapeng Yu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems